Maxcyte (MXCT) Net Margin (2020 - 2026)

Maxcyte (MXCT) reported Net Margin of 49.22% for Q1 2026, up 12945.0% year-over-year from N/an in Q1 2025, and down 124.46% on a QoQ basis from 201.22% in Q4 2025.

Maxcyte (MXCT) has 7 years of Net Margin data on file, last reported at 49.22% in Q1 2026.

  • Quarterly Net Margin rose 12945.0% year-over-year to 49.22% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 223.09% (down 7148.0% YoY) and the FY2025 annual result came in at 212.96%, down 10667.0% from the prior year.
  • Net Margin retreated to 49.22% in Q1 2026 per MXCT's latest filing, from 201.22% in the prior quarter.
  • Across five years, Net Margin topped out at 201.22% in Q4 2025 and bottomed at 270.72% in Q3 2023.
  • The 5-year median for Net Margin is 121.9% (2024), against an average of 106.83%.
  • The widest annual swing landed in 2023, when Net Margin plunged 26663 bps; it then surged 32312 bps in 2025.
  • Tracing MXCT's Net Margin over 5 years: stood at 155.66% in 2022, then plunged by 171 bps to 110.98% in 2023, then retreated by 10 bps to 121.9% in 2024, then surged by 265 bps to 201.22% in 2025, then plunged by 124 bps to 49.22% in 2026.
  • Per Business Quant, the three latest MXCT Net Margin figures stand at 49.22% (Q1 2026), 201.22% (Q4 2025), and 181.81% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 9.65%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 12.38%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 12.75%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.00%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 16.74%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 8.01%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Maxcyte 129.85 Mn 129.85 Mn 8.08 Mn -49.22%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -49.22%
Dec 31, 2025 201.22%
Sep 30, 2025 -181.81%
Jun 30, 2025 -212.17%
Mar 31, 2025 -178.67%
Dec 31, 2024 -121.90%
Sep 30, 2024 -141.56%
Jun 30, 2024 -188.86%
Mar 31, 2024 -170.59%
Dec 31, 2023 -110.98%
Sep 30, 2023 -270.72%
Jun 30, 2023 -116.24%
Mar 31, 2023 -219.22%
Dec 31, 2022 155.66%
Sep 30, 2022 -89.95%
Jun 30, 2022 -85.97%
Mar 31, 2022 -35.10%
Dec 31, 2021 224.55%
Sep 30, 2021 -47.79%
Jun 30, 2021 -62.21%
Mar 31, 2021 -167.62%
Dec 31, 2020 -268.84%
Sep 30, 2020 -66.36%
Jun 30, 2020 -129.14%